Analysis of risk factors and a prediction model for rebleeding in liver cirrhosis patients with esophagogastric variceal bleeding

doi:10.4254/wjh.123456

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 9

This Article

(1)

(0)

(5)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Hepatol. Sep 27, 2026; 18(9): 123456
Published online Sep 27, 2026. doi: 10.4254/wjh.123456

Table 2 Comparison of laboratory tests between non-rebleeding group and rebleeding group, median (interquartile range)

Variable	Non-rebleeding group (n = 68)	Rebleeding group (n = 62)	Statistic	P value
WBC	4.44 (3.25-6.57)	5.57 (3.73-7.17)	Z = -1.522	0.128
RBC	3.75 (3.17-4.22)	2.75 (2.40-3.36)	Z = -4.247	< 0.001
PLT	85.00 (65.50-124.25)	84.50 (66.25-115.75)	Z = -0.261	0.794
LYM	1.15 (0.80-1.46)	0.95 (0.61-1.22)	Z = -2.156	0.031
RDW-SD	46.85 (43.25-53.25)	48.55 (44.27-54.35)	Z = -0.958	0.338
RDW-CV	14.85 (13.70-18.22)	16.55 (15.60-19.75)	Z = -2.862	0.004
RDW-CV/LYM	14.59 (9.89-22.41)	18.88 (13.54-27.71)	Z = -2.832	0.005
RDW-CV/PLT	0.17 (0.11-0.28)	0.20 (0.14-0.28)	Z = -1.369	0.171
PLR	74.05 (52.62-106.95)	92.80 (60.77-165.13)	Z = -1.834	0.067
NLR	2.44 (1.51-3.82)	4.01 (2.73-6.40)	Z = -4.093	< 0.001
Platelet hematocrit	0.09 (0.06-0.13)	0.08 (0.06-0.10)	Z = -0.507	0.612
ALb	33.00 (28.50-36.32)	31.80 (29.05-34.55)	Z = -0.848	0.396
A/G	1.11 (0.89-1.36)	1.27 (0.97-1.47)	Z = -1.834	0.067
DBIL	12.30 (7.33-34.57)	15.35 (9.80-28.15)	Z = -0.739	0.460
TBIL	28.05 (15.15-62.15)	27.05 (19.40-44.55)	Z = -0.019	0.985
AST	42.50 (29.00-59.50)	39.50 (28.25-90.50)	Z = -0.893	0.372
ALT	28.00 (18.00-45.25)	32.00 (19.25-45.00)	Z = -0.415	0.678
CK-MB	30.50 (20.00-41.25)	35.00 (23.00-51.25)	Z = -2.124	0.034
BUN	4.20 (3.25-5.41)	6.84 (4.81-10.10)	Z = -4.561	< 0.001
CR	69.00 (59.00-85.25)	67.00 (58.25-91.50)	Z = -0.049	0.961
UA	284.00 (241.00-366.50)	299.00 (228.50-386.50)	Z = -0.040	0.968
TG	0.87 (0.66-1.24)	0.85 (0.73-1.43)	Z = -0.566	0.571
TC	3.88 (3.21-4.41)	3.12 (2.53-4.01)	Z = -3.242	0.001
HDL-C	1.08 (0.76-1.31)	0.88 (0.62-1.21)	Z = -1.485	0.138
LDL-C	2.00 (1.39-2.48)	1.71 (1.38-2.58)	Z = -0.145	0.885
PTA	58.00 (48.15-70.20)	56.60 (48.70-70.20)	Z = -0.165	0.869
PT	14.25 (13.00-15.77)	14.80 (13.03-16.40)	Z = -0.783	0.433
INR	1.24 (1.13-1.44)	1.30 (1.13-1.45)	Z = -0.879	0.379
APTT	33.15 (28.35-40.58)	30.95 (26.10-36.05)	Z = -1.925	0.054
TT	19.05 (17.70-20.42)	18.80 (17.55-20.28)	Z = -0.737	0.461
FIB	1.79 (1.22-2.21)	1.83 (1.24-2.29)	Z = -0.056	0.955
D-D	1.10 (0.38-4.06)	1.12 (0.52-3.65)	Z = -0.012	0.991
PCT	0.07 (0.03-0.12)	0.21 (0.10-0.37)	Z = -4.541	< 0.001

WBC: White blood cell; RBC: Red blood cell; PLT: Platelet; LYM: Lymphocyte; RDW-SD: Red blood cell distribution width-standard deviation; RDW-CV: Red blood cell distribution width-coefficient of variation; RDW-CV/LYM: Red blood cell distribution width coefficient of variation to lymphocyte ratio; RDW-CV/PLT: Red blood cell distribution width coefficient of variation to platelet count ratio; PLR: Platelet-to-lymphocyte ratio; NLR: Neutrophil-to-lymphocyte ratio; ALb: Albumin; A/G: Albumin-to-globulin ratio; DBIL: Direct bilirubin; TBIL: Total bilirubin; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; CK-MB: Creatine kinase isoenzyme; BUN: Urea nitrogen; CR: Creatinine; UA: Uric acid; TG: Triglyceride; TC: Total cholesterol; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; PTA: Prothrombin time activity; PT: Prothrombin time; INR: International normalized ratio; APTT: Activated partial thromboplastin time; TT: Thrombin time; FIB: Fibrinogen; D-D: D-dimer; PCT: Procalcitonin.

Full Size Table

Citation: Li PP, Zhong X, Zhang DY, Bai FH. Analysis of risk factors and a prediction model for rebleeding in liver cirrhosis patients with esophagogastric variceal bleeding. World J Hepatol 2026; 18(9): 123456
URL: https://www.wjgnet.com/1948-5182/full/v18/i9/123456.htm
DOI: https://dx.doi.org/10.4254/wjh.123456

Li PP, Zhong X, Zhang DY, Bai FH. Analysis of risk factors and a prediction model for rebleeding in liver cirrhosis patients with esophagogastric variceal bleeding. World J Hepatol 2026; 18(9): 123456 [DOI: 10.4254/wjh.123456]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.